HIV ANTI-CD40.HIV5PEP

N/A

Report date: 2025/03/20 15:19:48

Base Information

Drug NameHIV ANTI-CD40.HIV5PEP
Drug Alias Namedendritic-cell vaccine (LinKinVax)anti-CD40.HIV5pep (LinKinVax)
ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 modulators
TargetsTumor necrosis factor receptor superfamily member 5
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLinKinVax
China Registration ClassN/A

Develop Information

Active CompaniesLinKinVax
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A